Prof. MD. Bekir Kuru

Education and Specialization

• 1972–1979 Hacettepe University, Faculty of Medicine
  
• 1982–1987 Residency in General Surgery, Taksim Training and Research Hospital, Ministry of Health
  
• 1998 Certificate of Participation – Design, Conduct, Presentation Principles and Quality Control of Clinical Research, TÜBİTAK and Turkish Medical Association Course
  
• 2012 Breast and Thyroid Surgery Clinic, Memorial Sloan Kettering Cancer Center (MSKCC), New York, USA
  
• 2006 Associate Professorship in General Surgery, Ankara Oncology Training and Research Hospital, Ministry of Health
  
• 2012 Specialization in Surgical Oncology, Ondokuz Mayıs University, Faculty of Medicine
  
• 2012 Professorship in General Surgery, Ondokuz Mayıs University, Faculty of Medicine

Experience

• 1979 Physician, Hasköy Health Center, Muş (Ministry of Health)
  
• 1987–1998 General Surgery Specialist, State Hospitals in Yozgat / Yerköy / Lice / Bingöl / Amasya
  
• 1998–2008 General Surgery Specialist, Ankara Oncology Training and Research Hospital, Ministry of Health
  
• 2008–2022 Faculty Member, Department of General Surgery, Ondokuz Mayıs University, Faculty of Medicine
  
• 2022–2025 Atasam Medical Center and Atasam Hospital

Professional Memberships

• Turkish Surgical Association
  
• Turkish Federation of Breast Diseases
  
• Samsun Breast Association
  
• Turkish Medical Association, Samsun Medical Chamber

 

More than 60 international publicationswith 2,193 citations.
H-index: 24.

• 2022: Agcaoglu O, Sezer A, Makay O, Erdogan MF, Bayram F, Guldiken S, Raffaelli M, Sonmez YA, Lee YS, Vamvakidis K, Mihai R, Duh QY, Akinci B, Alagol F, Almquist M, Barczynski M, Bayraktaroglu T, Berber E, Bukey Y, Cakmak GK, Canturk NZ, Canturk Z, Celik M, Celik O, Ceyhan BO, Cherenko S, Clerici T, Coombes DS, Demircan O, Deyneli O, Dionigi G, Emre AU, Erbil Y, Filiz AI, Gozu HI, Gurdal SO, Gurleyik G, Haciyanli M, Kebudi A, Kim S, Koutelidakis G, Kuru B, Mert M, Oruk GG, Ozbas S, Palazzo F, Pandev R, Riss P, Sabuncu T, Sahin I, Sakman G, Saygili F, Senyurek YG, Sleptsov I, Van Slycke S, Teksoz S, Terzioglu T, Tezelman S, Tunca F, Ugurlu MU, Uludag M, Villar-Del-Moral J, Vriens M, Yazici D. Management of endocrine surgical disorders during COVID-19 pandemic: expert opinion for non-surgical options.Updates Surg. 2022 Feb;74(1):325-335.
• 2021: Kuru B, Kefeli M, Danaci M. Comparison of 5 Thyroid Ultrasound Stratification Systems for Differentiation of Benign and Malignant Nodules and to Avoid Biopsy Using Histology as Reference Standard. Endocr Pract. 2021 Nov;27(11):1093-1099. doi: 10.1016/j.eprac.2021.04.411. Epub 2021 Apr 28.
• 2020: Çakmak GK, Emiroğlu S, Sezer A, Canturk NZ, Yeniay L, Kuru B, Karanlık H, Soyder A, Gökgöz Ş, Sakman G, Ucuncu M, Akcay MN, Girgin S, Gurdal SO, Emiroglu M, Ozbas S, Öz AB, Arici C, Toktas O, Demircan O, Çalık A, Polat AK, Maralcan G, Demirer S, Ozmen V. Surgical Trends in Breast Cancer in Turkey: An Increase in Breast-Conserving Surgery. JCO Glob Oncol. 2020 Feb;6:285-292. doi: 10.1200/JGO.19.00275.
• 2020: Kuru B. The Adventure of Axillary Treatment in Early Stage Breast Cancer. Eur J Breast Health. 2020 Jan 1;16(1):1-15. doi: 10.5152/ejbh.2019.5157. eCollection 2020 Jan.
• 2018: Kuru B. Echoes from the 40th Annual San Antonio Breast Cancer Symposium, 2017. Eur J Breast Health. 2018 Apr 1;14(2):72-73. doi: 10.5152/ejbh.2018.3948. eCollection 2018 Apr.
• 2018: Kuru B, Yuruker S, Sullu Y, Bilge Gürsel B, Ozen N. Does a Close Surgical Margin for Ductal Carcinoma In Situ Associated with Invasive Breast Carcinoma Affect Breast Cancer Recurrence? Journal of Investigative Surgery. Published Online: 21 Dec 2018
• 2018: Kuru B, Kefeli M. Risk factors associated with malignancy and with triage to surgery in thyroid nodules classified as Bethesda category IV (FN/SFN). Diagn Cytopathol. 2018 Jun;46(6):489-494. doi: 10.1002/dc.23923. Epub 2018 Mar 10. PubMed PMID: 29524316.
• 2017: Kuru B, Yuruker S, Sullu Y, Gursel B, Ozen N. Management of the Axilla in T1-2 Breast Cancer Patients with Macrometastatic Sentinel Node Involvement Who Underwent Breast-Conserving Therapy. J Invest Surg. 2017 Sep 25:1-7
• 2017: Kuru B. Factors Influencing the Decision on Surgery or Observation for Patients with Bethesda Category 3 (AUS/FLUS). Ann Surg Oncol. 2017 Dec;24(Suppl 3):639. doi: 10.1245/s10434-017-6168-9. Epub 2017 Oct 30.
• 2017: Emiroğlu M, Kuru B, Gülçelik MA, Atahan MK, Sezer AY, Karaali C, Güllüoğlu B. The Main Topics at the Oncoplastic Breast Surgery Course and Expert Panel. J Breast Health. 2017 Jan 1;13(1):46-49.
• 2016: Kuru B, Sullu Y, Yuruker S, Koray Bayrak I, Ozen N. Factors predicting non-sentinel lymph node metastasis in T1-2 invasive breast cancer with 1-2 axillary sentinel lymph node metastases: Presentation of Ondokuz Mayis scoring system. J BUON. 2016 Sept-Oct;21(5):1129-1136. Erratum in: J BUON. 2016 Nov-Dec;21(6):1571. PubMed PMID: 27837614.
• 2016: Kuru B, Atmaca A, Kefeli M. Malignancy rate associated with Bethesda category III (AUS/FLUS) with and without repeat fine needle aspiration biopsy. Diagn Cytopathol. 2016 May;44(5):394-8. doi: 10.1002/dc.23456. Epub 2016 Feb 24.
• 2016: Kuru B, Atmaca A, Tarim IA, Kefeli M, Topgul K, Yoruker S, Elmali M, Danaci M. Risk factors associated with malignancy and with triage to surgery in thyroid nodules classified as Bethesda category III (AUS/FLUS). Eur J Surg Oncol. 2016 Jan;42(1):87-93. doi: 10.1016/j.ejso.2015.09.026. Epub 2015 Oct 19.
• 2015: Yuruker S, Koca B, Karabicak I, Kuru B, Ozen N. Percutaneous Endoscopic Gastrostomy: Technical Problems, Complications, and Management. Indian J Surg. 2015 Dec;77(Suppl 3):1159-64. doi: 10.1007/s12262-015-1227-6. Epub 2015 Jan 23.
• 2015: Kuru B. Should the patients with thyroid nodule who had benign fine-needle aspiration biopsy findings and suspicious ultrasonographic and clinical findings undergo surgery? Diagn Cytopathol. 2015 Dec;43(12):1037-8. doi: 10.1002/dc.23335. Epub 2015 Aug 25.
• 2015: Kuru B. Is Repeated Fine-Needle Aspiration Biopsy of Nodules with Bethesda Category III (Atypia of Undetermined Significance/Follicular Lesion of Undetermined Significance) Associated with a Decreased or Increased Malignancy Rate? Acta Cytol. 2015;59(1):118-119. doi: 10.1159/000375285. Epub 2015 Mar 7
• 2014: Koca B, Kuru B, Karabicak I, Yürüker SS, Ozen N. Prognostic factors affecting disease-free survival in patients at age 35 or younger with invasive breast cancer. Ann Ital Chir. 2014 May-Jun;85(3):249-53. PubMed PMID: 25074433.
• 2014: Koca B, Kuru B, Ozen N, Yoruker S, Bek Y. A breast cancer nomogram for prediction of non-sentinel node metastasis - validation of fourteen existing models. Asian Pac J Cancer Prev. 2014;15(3):1481-8. PubMed PMID: 24606487.
• 2013: Koca B, Kuru B, Yuruker S, Gokgul B, Ozen N. Factors affecting surgical margin positivity in invasive ductal breast cancer patients who underwent breast-conserving surgery after preoperative core biopsy diagnosis. J Korean Surg Soc. 2013 Mar;84(3):154-9. doi: 10.4174/jkss.2013.84.3.154. Epub 2013 Feb 27.
• 2013: Koca B, Topgül K, Yürüker SS, Cınar H, Kuru B. Non-operative treatment approach for blunt splenic injury: is grade the unique criterion? Ulus Travma Acil Cerrahi Derg. 2013 Jul;19(4):337-42. doi: 10.5505/tjtes.2013.89411.
• 2012: Gulcelik MA, Kuru B, Dincer H, Camlibel M, Yuksel UM, Yenidogan E, Reis E. Complications of completion versus total thyroidectomy. Asian Pac J Cancer Prev. 2012;13(10):5225-8. PubMed PMID: 23244139.
• 2012: Kuru B, Topgul K. The 2009 Revised American Thyroid Association Guidelines for Thyroid Cancer: the extent of surgery for thyroid carcinoma less than one and one half centimeters or low-risk thyroid carcinoma. Thyroid. 2012 Feb;22(2):225-6; author reply 226-7. doi: 10.1089/thy.2011.0027.
• 2011: Kuru B, Gulcelik MA, Topgul K, Ozaslan C, Dinc S, Dincer H, Bozgul M, Camlibel M, Alagol H. Application of sentinel node biopsy in breast cancer patients with clinically negative and positive axilla and role of axillary ultrasound examination to select patients for sentinel node biopsy. J BUON. 2011 Jul-Sep;16(3):454-9.
• 2011: Gulcelik MA, Dogan L, Camlibel M, Karaman N, Kuru B, Alagol H, Ozaslan C. Early complications of a reduction mammoplasty technique in the treatment of macromastia with or without breast cancer. Clin Breast Cancer. 2011 Dec;11(6):395-9. doi: 10.1016/j.clbc.2011.08.001. Epub 2011 Oct 10. 21993009.
• 2011: Kuru B. Prognostic factors for locoregional recurrence and survival in stage IIIC breast carcinoma: impact of adjuvant radiotherapy. Singapore Med J. 2011 Apr;52(4):289-98. PubMed PMID: 21552792.
• 2011: Topgül K, Yürüker SS, Kuru B. Single-incision laparoscopic cholecystectomy in a 6-month pregnant woman: a report of a case. Surg Laparosc Endosc Percutan Tech. 2011 Apr;21(2):e100-3.
• 2010: Kuru B, Gulcelik NE, Gulcelik MA, Dincer H. The false-negative rate of fine-needle aspiration cytology for diagnosing thyroid carcinoma in thyroid nodules. Langenbecks Arch Surg. 2010 Feb;395(2):127-32.
• 2010: Karabicak I, Kuru B, Topgül K, Angi S, Gün S, Yildiz L. Life threatening intestinal bleeding from intestinal peripheral nerve sheath tumor in a patient with type-1 neurofibromatosis. Am Surg. 2010 Apr;76(4):E3-4.
• 2009: Kuru B, Gulcelik NE, Gulcelik MA, Dincer H. Predictive index for carcinoma of thyroid nodules and its integration with fine-needle aspiration cytology. Head Neck. 2009 Jul;31(7):856-66. doi: 10.1002/hed.21049.
• 2008: Gulcelik NE, Gulcelik MA, Kuru B. Risk of malignancy in patients with follicular neoplasm: predictive value of clinical and ultrasonographic features. Arch Otolaryngol Head Neck Surg. 2008 Dec;134(12):1312-5.
• 2008: Kuru B, Camlibel M, Dinc S, Gulcelik MA, Gonullu D, Alagol H. Prognostic factors for survival in breast cancer patients who developed distant metastasis subsequent to definitive surgery. Singapore Med J. 2008 Nov;49(11):904-11.
• 2008: Kuru B. The sensitivity and the false negative rate of fine needle aspiration biopsy in thyroid nodule. Ann Surg. 2008 Aug;248(2):343-4; author reply 344.
• 2008: Kuru B. Re: The incidence of cancer and rate of false-negative cytology in thyroid nodules greater than or equal to 4 cm. Surgery. 2008 Jun;143(6):835-6.
• 2008: Kuru B. Triaging patients with thyroid nodules for surgery by fine needle aspiration cytology. Am J Surg. 2008 Jun;195(6):881-2. doi: 10.1016/j.amjsurg.2008.01.012. Epub 2008 Apr 16.
• 2008: Kuru B. Staging of invasive breast carcinoma patients with T4anyNM0 and T1-3N3M0. Ann Surg Oncol. 2008 Jun;15(6):1785-6; author reply 1787.
• 2007: Gulcelik MA, Gulcelik NE, Kuru B, Camlibel M, Alagol H. Prognostic factors determining survival in differentiated thyroid cancer. J Surg Oncol. 2007;96(7):598-604.
• 2007: Dinc S, Ozbirecikli B, Kuru B, Gulcelik MA, Ustun H, Alagol H, Oz M. Long term administration of granulocyte-macrophage colony stimulating factor decreases development of 1-2 dimethylhydrazine-induced colon cancer in rats.J Surg Oncol. 2007 Jan 1;95(1):12-21. doi: 10.1002/jso.20540.
• 2006: Kuru B, Bozgul M. The impact of axillary lymph nodes removed in staging of node-positive breast carcinoma. Int J Radiat Oncol Biol Phys. 2006;66(5):1328-34.
• 2006: Kuru B. Prognostic significance of total number of nodes removed, negative nodes removed, and ratio of positive nodes to removed nodes in node positive breast carcinoma. Eur J Surg Oncol. 2006 Dec;32(10):1082-8. Epub 2006 Aug 1.
• 2006: Gulcelik MA, Gulcelik NE, Dinc S, Kuru B, Camlibel M, Alagol H. The incidence of hyperthyroidism in patients with thyroid cancer in an area of iodine deficiency. J Surg Oncol. 2006 Jul 1;94(1):35-9. PubMed PMID: 16788941.
• 2006: Dinc S, Ozaslan C, Kuru B, Karaca S, Ustun H, Alagol H, Renda N, Oz M. Methylene blue prevents surgery-induced peritoneal adhesions but impairs the early phase of anastomotic wound healing. Can J Surg. 2006 Oct;49(5):321-8.
• 2006: Dinc S, Durmus E, Gulcelik MA, Kuru B, Ustun H, Renda N, Alagol H. Effects of beta-D-glucan on steroid-induced impairment of colonic anastomotic healing. Acta Chir Belg. 2006 Jan-Feb;106(1):63-7
• 2005: Kuru B, Camlibel M, Dinc S, Gulcelik MA, Atalay C, Alagol H. A comparison of the outcomes of non-randomised chemotherapy regimens in node positive breast cancer. J Exp Clin Cancer Res. 2005 Sep;24(3):363-72.
• 2005: Kuru B, Dinc S, Elitok O, Gulcelik MA, Alagol H. Efficacy of granulocyte-macrophage colony-stimulating factor on the survival of ischaemic skin flaps in rats. Scand J Plast Reconstr Surg Hand Surg. 2005;39(4):193-6.
• 2004: Kuru B, Camlibel M, Dinc S, Gulcelik MA, Alagol H. Prognostic significance of apex axillary invasion for locoregional recurrence and effect of postmastectomy radiotherapy on overall survival in node-positive breast cancer patients. World J Surg. 2004 Mar;28(3):236-41.
• 2004: Songür N, Kuru B, Kalkan F, Ozdilekcan C, Cakmak H, Hizel N. Serum interleukin-6 levels correlate with malnutrition and survival in patients with advanced non-small cell lung cancer. Tumori. 2004 Mar-Apr;90(2):196-200.
• 2004: Ozaslan C, Kuru B. Lymphedema after treatment of breast cancer. Am J Surg. 2004 Jan;187(1):69-72. PubMed PMID: 14706589.
• 2004: Dinc S, Ozbirecikli B, Gulcelik MA, Ergeneci D, Kuru B, Erdem E, Caydere M, Alagol H. The effects of locally injected granulocyte macrophage-colony stimulating factor on the healing of intraoperatively irradiated intestinal anastomoses in rats. J Exp Clin Cancer Res. 2004 Mar;23(1):77-82.
• 2004: Dinc S, Gulcelik MA, Kuru B, Ergeneci D, Camlibel M, Caydere M, Alagol H. Effects of locally applied recombinant human granulocyte-macrophage colony-stimulating factor on ischemic bowel anastomoses in rat. Eur Surg Res. 2004 Jan-Feb;36(1):59-63. doi: 10.1159/000075076.
• 2003: Kuru B, Camlibel M, Dinc S, Gulcelik MA, Alagol H. Prognostic significance of axillary node and infraclavicular lymph node status after mastectomy. Eur J Surg Oncol. 2003 Dec;29(10):839-44. PubMed PMID: 14624774.
• 2003: Erdem E, Gülçelik MA, Kuru B, Alagöl H. Comparison of completion thyroidectomy and primary surgery for differentiated thyroid carcinoma. Eur J Surg Oncol. 2003 Nov;29(9):747-9. PubMed PMID: 14602494.
• 2003: Kuru B, Camlibel M, Gulcelik MA, Alagol H. Prognostic factors affecting survival and disease-free survival in lymph node-negative breast carcinomas. J Surg Oncol. 2003 Jul;83(3):167-72. PubMed PMID: 12827686.
• 2002: Kuru B, Ozaslan C, Ozdemir P, Dinç S, Camlibel M, Alagöl H. Risk factors for breast cancer in Turkish women with early pregnancies and long-lasting lactation--a case-control study. Acta Oncol. 2002;41(6):556-61. PubMed PMID: 12546529.
• 2002: Kuru B, Camlibel M, Dinç S, Erdem E, Alagöl H. Prognostic factors affecting local recurrence and survival for operable rectal cancers. J Exp Clin Cancer Res. 2002 Sep;21(3):329-35. PubMed PMID: 12385573.
• 2002: Kuru B, Ozaslan C, Yalman K, Camlibel M. Serum progesterone levels in patients with gastric and colorectal cancers. Acta Chir Belg. 2002 Apr;102(2):122-5. PubMed PMID: 12051085.
• 1980: Yalaz K, Renda Y, Kuru B. Hereditary sensory radicular neuropathy (HSN). Turk J Pediatr. 1980 Jan-Apr;22(1-2):32-8.